Status:
COMPLETED
Substance Abuse Treatment for High Risk Chronic Pain Patients on Opioid Therapy
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Substance Abuse
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic back pain patients are often dismissed from a pain center or a primary care practice when they are noncompliant with opioid therapy, instead of being offered treatments to reduce misuse and to...
Detailed Description
This study will evaluate drug misuse behavior over 6 months with the use of self-report questionnaires, physician ratings, urine toxicology screens, and electronic diary data.
Eligibility Criteria
Inclusion
- chronic pain for \>6 months
- history of taking daily opioids for pain for \>6 months
- average \>3 on a pain intensity scale of 0 to 10 over past week
- able to speak and understand English
- chronic neck or back pain as primary pain complaint
- willingness to participate
Exclusion
- current opioid addiction (M.I.N.I. Section K)
- current diagnosis of cancer or any other malignant disease
- acute osteomyelitis or acute bone disease
- nonambulatory
- present or past DSM-IV diagnosis of schizophrenia, delusional disorder, psychotic disorder, or dissociative disorder
- pregnancy
- any clinically unstable systemic illness judged to interfere with treatment
- an acute condition requiring surgery
- taking opioids intermittently
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2011
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT00988962
Start Date
July 1 2009
End Date
June 1 2011
Last Update
June 27 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital Pain Management Center
Chestnut Hill, Massachusetts, United States, 02467